Other specified abnormalities of plasma proteins
ICD-10 R77.8 is a billable code used to indicate a diagnosis of other specified abnormalities of plasma proteins.
R77.8 encompasses a range of abnormalities in plasma proteins that do not fit into more specific categories. Plasma proteins, including albumin, globulins, and fibrinogen, play crucial roles in maintaining oncotic pressure, transporting substances, and facilitating clotting. Abnormalities may manifest as altered levels of these proteins, which can indicate various underlying conditions such as liver disease, kidney disorders, inflammatory states, or malignancies. Symptoms may include edema, jaundice, or signs of bleeding, depending on the specific protein involved and the underlying pathology. Laboratory findings may reveal abnormal serum protein electrophoresis patterns, altered albumin/globulin ratios, or changes in coagulation profiles. Accurate diagnosis often requires correlating clinical findings with laboratory results and may necessitate further testing to identify the underlying cause of the abnormality.
Detailed patient history, physical examination findings, and lab results must be documented to support the diagnosis.
Patients presenting with unexplained edema, jaundice, or abnormal lab results during routine check-ups.
Consideration of chronic conditions such as liver cirrhosis or nephrotic syndrome that may lead to plasma protein abnormalities.
Acute care documentation must include immediate lab results and clinical assessments.
Patients with acute liver failure or severe infections presenting with abnormal coagulation profiles.
Rapid assessment and documentation of symptoms and lab findings are critical for timely intervention.
Used to evaluate plasma protein abnormalities.
Document the reason for the test and correlate with clinical findings.
Internal medicine and hematology often utilize this procedure for diagnosis.
Document the specific abnormal lab findings, the clinical context, and any relevant patient history that supports the diagnosis of other specified abnormalities of plasma proteins.
